Metastatic small cell neuroendocrine carcinoma of the cervix treated with the PD-1 inhibitor, nivolumab: a case report

BACKGROUND: Nivolumab is an immune checkpoint inhibitor specific for the programmed death 1 (PD-1) receptor that has led to clinical responses in many cancer types. Identifying biomarkers predictive of response to PD-1 blockade is an area of active investigation. CASE PRESENTATION: We present a pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Paraghamian, Sarah E., Longoria, Teresa C., Eskander, Ramez N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5290639/
https://www.ncbi.nlm.nih.gov/pubmed/28174665
http://dx.doi.org/10.1186/s40661-017-0038-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5290639/
https://www.ncbi.nlm.nih.gov/pubmed/28174665
http://dx.doi.org/10.1186/s40661-017-0038-9

Ejemplares similares